Century Therapeutics (IPSC) Competitors $0.50 -0.01 (-1.45%) Closing price 04:00 PM EasternExtended Trading$0.50 0.00 (-0.18%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPSC vs. SXTC, NVCT, MCRB, LFVN, KYTX, MEIP, BDTX, GLSI, MIST, and ELDNShould you be buying Century Therapeutics stock or one of its competitors? The main competitors of Century Therapeutics include China SXT Pharmaceuticals (SXTC), Nuvectis Pharma (NVCT), Seres Therapeutics (MCRB), Lifevantage (LFVN), Kyverna Therapeutics (KYTX), MEI Pharma (MEIP), Black Diamond Therapeutics (BDTX), Greenwich LifeSciences (GLSI), Milestone Pharmaceuticals (MIST), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "pharmaceutical products" industry. Century Therapeutics vs. Its Competitors China SXT Pharmaceuticals Nuvectis Pharma Seres Therapeutics Lifevantage Kyverna Therapeutics MEI Pharma Black Diamond Therapeutics Greenwich LifeSciences Milestone Pharmaceuticals Eledon Pharmaceuticals China SXT Pharmaceuticals (NASDAQ:SXTC) and Century Therapeutics (NASDAQ:IPSC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation. Is SXTC or IPSC more profitable? China SXT Pharmaceuticals has a net margin of 0.00% compared to Century Therapeutics' net margin of -19.10%. China SXT Pharmaceuticals' return on equity of 0.00% beat Century Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Century Therapeutics -19.10%-11.53%-6.94% Which has more volatility and risk, SXTC or IPSC? China SXT Pharmaceuticals has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, Century Therapeutics has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Do institutionals & insiders have more ownership in SXTC or IPSC? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. Comparatively, 50.2% of Century Therapeutics shares are held by institutional investors. 4.0% of China SXT Pharmaceuticals shares are held by company insiders. Comparatively, 5.0% of Century Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings & valuation, SXTC or IPSC? China SXT Pharmaceuticals has higher earnings, but lower revenue than Century Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M98.31-$3.30MN/AN/ACentury Therapeutics$6.59M6.59-$126.57M-$0.29-1.73 Do analysts prefer SXTC or IPSC? Century Therapeutics has a consensus price target of $3.75, indicating a potential upside of 645.68%. Given Century Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Century Therapeutics is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Century Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor SXTC or IPSC? In the previous week, China SXT Pharmaceuticals and China SXT Pharmaceuticals both had 1 articles in the media. China SXT Pharmaceuticals' average media sentiment score of 0.00 equaled Century Therapeutics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment China SXT Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Century Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCentury Therapeutics beats China SXT Pharmaceuticals on 7 of the 12 factors compared between the two stocks. Get Century Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IPSC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPSC vs. The Competition Export to ExcelMetricCentury TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.08M$2.61B$5.81B$10.01BDividend YieldN/A49.23%5.29%4.53%P/E Ratio-1.7323.2075.6926.28Price / Sales6.59683.56539.36121.13Price / CashN/A167.9837.2059.76Price / Book0.265.3411.506.41Net Income-$126.57M$32.95M$3.28B$270.56M7 Day Performance4.77%2.76%1.30%3.01%1 Month Performance-0.87%29.32%11.25%9.74%1 Year Performance-67.34%1.14%59.54%26.68% Century Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPSCCentury Therapeutics2.1586 of 5 stars$0.50-1.5%$3.75+645.7%-65.0%$44.08M$6.59M-1.73170Analyst UpgradeGap DownSXTCChina SXT Pharmaceuticals0.1569 of 5 stars$1.46flatN/A-64.0%$169.40M$1.74M0.0090NVCTNuvectis Pharma3.2386 of 5 stars$6.56+0.5%$15.33+133.7%+3.6%$167MN/A-5.618MCRBSeres Therapeutics2.8336 of 5 stars$18.94-0.3%$73.67+288.9%+19.8%$165.81M$126.32M-4.12330News CoverageGap UpLFVNLifevantage4.1522 of 5 stars$13.10flat$30.50+132.8%+17.1%$164.90M$200.16M18.99260News CoverageEarnings ReportAnalyst DowngradeKYTXKyverna Therapeutics2.3618 of 5 stars$3.71+0.3%$16.60+347.4%-46.9%$160.44M$7.03M-1.0196Gap UpMEIPMEI Pharma1.3466 of 5 stars$4.86-6.5%N/A-3.2%$159.59M$65.30M-1.02100News CoveragePositive NewsAnalyst DowngradeGap DownBDTXBlack Diamond Therapeutics3.4235 of 5 stars$2.75-3.5%$12.40+350.9%-43.5%$156.57MN/A11.9690Positive NewsGLSIGreenwich LifeSciences1.1706 of 5 stars$11.48+0.2%$42.00+265.9%-23.0%$156.48MN/A-8.443MISTMilestone Pharmaceuticals1.787 of 5 stars$1.84+1.7%$5.00+171.7%+19.9%$156.39M$1M-2.1930Positive NewsGap UpELDNEledon Pharmaceuticals2.1332 of 5 stars$2.59+0.8%$10.00+286.1%+1.6%$155.09MN/A-2.2110Positive News Related Companies and Tools Related Companies SXTC Alternatives NVCT Alternatives MCRB Alternatives LFVN Alternatives KYTX Alternatives MEIP Alternatives BDTX Alternatives GLSI Alternatives MIST Alternatives ELDN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPSC) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPSC Stock Alerts